RxDoctor Payments Data

Kamran Shayesteh, DO

Plastic and Reconstructive Surgery · Johnstown, PANPI 1336150564

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $30,563 of the $47,392 with a category attached, or 64.5%. Kerecis Limited accounts for 93.3% of it on its own, with 19 other manufacturers making up the rest. Among plastic and reconstructive surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,392in general payments, 2019–2025

Across 99 payments — averaging $478.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$44K
  • Musculoskeletal Transplant Foundation Inc.$1K
  • Integra Lifesciences Corporation$618
  • Johnson & Johnson$463
  • AstraZeneca$125
  • Smith+Nephew$110
  • plus $464 from 14 others
$1,000in research payments, 2019–2025

Across 1 payment — averaging $1000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kerecis Limited$1K

What the payments were for

  • Consulting fees$1,2753%
  • Speaking & faculty fees$30,56364%
  • Travel & lodging$6,42314%
  • Food & beverage$4,1079%
  • Education$5,02511%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,392 in reported general payments places this provider in the 95th percentile of 108 plastic and reconstructive surgery providers in Pennsylvania.

See all plastic and reconstructive surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$61,669
Medicare patients
166
Services billed
447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil45$2,677
Cephalexin15$66
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim21$52

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Johnstown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →